investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Pharmaceutical  ↓1.96   Disease: Oncology ↓1.36   Cancer fight ↓1.36 «See more»   Covid (fighting) ↑3.39   1% Dividends ↑4.7   Disease: Liver ↑8.7

Life Sciences stock segment: trending tickers

ACTG Acacia Research Corporation - Common Stock 0.83% 0.83% 0 + Acquisitions/Investing, Technology, Life Sciences, Finance

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/934549/000119312524099084/0001193125-24-099084-index.htm
8-K - ACACIA RESEARCH CORP (0000934549) (Filer)
+ My List
ATNFW 180 Life Sciences Corp. - Warrant 0.00% 0 + Life Sciences, Medicine
+ My List
IDXG Interpace Biosciences, Inc. - Common Stock -1.36% -1.36% 0 + Medicine, Disease: Oncology, Cancer fight, Life Sciences

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1054102/000149315224012464/0001493152-24-012464-index.htm
10-K - INTERPACE BIOSCIENCES, INC. (0001054102) (Filer)
+ My List
LFVN Lifevantage Corporation - Common Stock 4.70% up 0.61% 4.09 + Healthcare, Life Sciences, 1% Dividends

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/0000849146-24-000039-index.htm
8-K - Lifevantage Corp (0000849146) (Filer)
+ My List
NDRA ENDRA Life Sciences Inc. - Common Stock 8.70% 8.70% 0 + Life Sciences, Disease: Liver

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1681682/000165495424003873/0001654954-24-003873-index.htm
10-K - ENDRA Life Sciences Inc. (0001681682) (Filer)
+ My List
OPRX OptimizeRx Corporation - Common Stock -0.73% down 1.47% -2.2 + Healthcare, Life Sciences, SaaS

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1448431/000121390024034128/0001213900-24-034128-index.htm
8-K - OptimizeRx Corp (0001448431) (Filer)
+ My List
RSSS Research Solutions, Inc - Common Stock -1.96% -1.96% 0 + Life Sciences, SaaS, Pharmaceutical

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1386301/000110465924048029/0001104659-24-048029-index.htm
8-K - Research Solutions, Inc. (0001386301) (Filer)
+ My List
TOMZ TOMI Environmental Solutions, Inc. - Common Stock 3.39% 3.39% 0 + Disease: Infectious, Medicine, Equipment, Life Sciences, Food, Covid (fighting)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/314227/000165495424002073/0001654954-24-002073-index.htm
8-K - TOMI Environmental Solutions, Inc. (0000314227) (Filer)
+ My List
WVE Wave Life Sciences Ltd. - Ordinary Shares 2.30% down 3.13% -0.83 + Medicine, Biotechnology, Life Sciences

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1631574/000095017024026876/0000950170-24-026876-index.htm
10-K - Wave Life Sciences Ltd. (0001631574) (Filer)
+ My List
XGN Exagen Inc. - Common Stock 2.14% down 5.00% -2.86 + Life Sciences, Medicine, Immunology

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1274737/000127473724000022/0001274737-24-000022-index.htm
10-K - EXAGEN INC. (0001274737) (Filer)
+ My List
MASS 908 Devices Inc. - Common Stock 1.61% up 1.43% 0.18 + Devices, Biopharma, Life Sciences

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1555279/000155837024002818/0001558370-24-002818-index.htm
10-K - 908 Devices Inc. (0001555279) (Filer)
+ My List
VINC Vincerx Pharma, Inc. - Common Stock -1.05% down 0.00% -1.05 + Biopharma, Medicine, Life Sciences

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1796129/000119312524089665/0001193125-24-089665-index.htm
8-K - Vincerx Pharma, Inc. (0001796129) (Filer)
+ My List
ALPP Alpine 4 Holdings, Inc. - Class A Common Stock -2.63% -2.63% 0 + Acquisitions/Investing, Life Sciences

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1606698/000162828024012587/0001628280-24-012587-index.htm
8-K - ALPINE 4 HOLDINGS, INC. (0001606698) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.